Kumar Neil — Chief Executive Officer
Insider trading activity for Kumar Neil sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Chief Executive Officer
- Company: BridgeBio Pharma, Inc.
- Total insider trades: 58
- Total buy volume: $0
- Total sell volume: $23.0M
- Last trade: Sep 21, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 1,279 | $89K |
| Sep 17, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 8,721 | $602K |
| Aug 19, 2026 | Kumar Neil | BBBIO BBBIO | SELL | 10,000 | $840K |
| Aug 18, 2026 | Kumar Neil | BBBIO BBBIO | SELL | 34,980 | $2.9M |
| Aug 16, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | OTHER | 33,544 | N/A |
| Aug 16, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | OTHER | 33,544 | N/A |
| Jun 16, 2026 | Kumar Neil | BBOT BridgeBio Oncology Therapeutics, Inc. | OTHER | 31,675 | N/A |
| Jun 5, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 4,415 | $304K |
| Jun 5, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 8,437 | $573K |
| Jun 5, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 7,148 | $480K |
| Jun 5, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 4,416 | $305K |
| Jun 5, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 8,437 | $573K |
| Jun 5, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 7,147 | $480K |
| Jun 4, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 450 | $31K |
| Jun 4, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 15,921 | $1.1M |
| Jun 4, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 1,429 | $95K |
| Jun 4, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 2,200 | $145K |
| Jun 4, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 450 | $31K |
| Jun 4, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 15,921 | $1.1M |
| Jun 4, 2026 | Kumar Neil | BBIO BridgeBio Pharma, Inc. | SELL | 1,429 | $95K |